C. Solano

Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor

E. Forcade, H. Finel, A. Boumendil, 2024, Bone marrow transplantation.

Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.

M. Mohty, F. Bonifazi, Z. Perić, 2024, The Lancet. Haematology.

Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis in HLA-matched and haploidentical donor transplants for patients with Hodgkin lymphoma: a comparative study of the LWP EBMT.: GVHD prophylaxis for patients with Hodgkin lymphoma.

J. Pérez-Simón, L. Castagna, A. Dominietto, 2023, Transplantation and cellular therapy.

PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT

J. Pérez-Simón, I. Sakellari, P. Matteucci, 2024, Blood advances.